Profile data is unavailable for this security.
About the company
Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in mail order business and functional materials business. The Company operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The Company is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
- Revenue in JPY (TTM)65.08bn
- Net income in JPY4.76bn
- Incorporated1997
- Employees670.00
- LocationPharma Foods International Co Ltd1-49, Goryo Ohara, Nishikyo-KuKYOTO-SHI 615-8245JapanJPN
- Phone+81 753948600
- Fax+81 753940099
- Websitehttps://www.pharmafoods.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 2929:TYO since announced | Transaction value |
|---|---|---|
| Daicel Corp-Healthcare Mail Order Business | -43.86% | -- |
Data delayed at least 20 minutes, as of May 23 2024 04:46 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncolys Biopharma Inc | 28.04m | -1.98bn | 13.04bn | 34.00 | -- | 7.39 | -- | 465.02 | -107.77 | -107.77 | 1.52 | 84.14 | 0.0127 | 0.00 | 0.1476 | 824,647.10 | -89.46 | -45.75 | -101.52 | -51.86 | 100.00 | 60.46 | -7,058.44 | -233.66 | 8.82 | -- | 0.1416 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Stella Pharma Corp | 269.49m | -763.75m | 13.21bn | 46.00 | -- | 5.56 | -- | 49.01 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | -- | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -379.39 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| Ohki Healthcare Holdings Co Ltd | 334.66bn | 2.21bn | 14.16bn | 576.00 | 6.27 | 0.493 | 7.86 | 0.0423 | 160.46 | 160.46 | 24,294.61 | 2,040.70 | 2.56 | 13.33 | 4.74 | -- | 1.63 | 1.85 | 7.07 | 8.42 | 5.14 | 6.16 | 0.6356 | 0.7178 | 0.8922 | -- | 0.1993 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Microwave Chemical Co Ltd | 1.86bn | -944.90m | 18.18bn | 59.00 | -- | 21.24 | -- | 9.76 | -60.75 | -60.75 | 120.53 | 54.81 | 0.7495 | 31.73 | 4.31 | -- | -38.01 | -- | -52.71 | -- | 60.13 | -- | -50.71 | -- | 1.81 | 26.20 | 0.3803 | -- | 53.32 | -- | -1,353.29 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.33bn | -2.90bn | 19.85bn | 208.00 | -- | 2.65 | -- | 3.14 | -58.49 | -58.49 | 129.20 | 148.04 | 0.462 | 2.04 | 3.44 | 30,432,690.00 | -21.14 | -- | -26.00 | -- | 44.27 | -- | -45.75 | -- | 2.92 | -- | 0.2811 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Astena Holdings Co Ltd | 52.63bn | 1.62bn | 20.20bn | 1.40k | 12.03 | 0.6824 | 5.25 | 0.3839 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| Medical Data Vision Co Ltd | 6.25bn | 688.02m | 20.29bn | 262.00 | 28.15 | 4.86 | 26.84 | 3.25 | 18.01 | 18.01 | 163.57 | 104.34 | 1.15 | 282.07 | 7.84 | 23,847,790.00 | 12.18 | 16.16 | 17.01 | 20.88 | 77.43 | 81.90 | 10.55 | 15.52 | 2.72 | 13.48 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
| Fuso Pharmaceutical Industries Ltd | 55.41bn | 1.38bn | 21.39bn | 1.31k | 14.16 | 0.5275 | 7.46 | 0.386 | 159.77 | 159.77 | 6,435.26 | 4,290.49 | 0.7474 | 3.12 | 2.43 | -- | 1.86 | 1.91 | 3.06 | 3.09 | 24.98 | 26.92 | 2.49 | 2.69 | 1.04 | 54.56 | 0.2576 | 41.17 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Cuorips Inc | 23.10m | -632.18m | 24.90bn | 46.00 | -- | 4.15 | -- | 1,077.84 | -86.04 | -86.04 | 3.14 | 752.26 | 0.0047 | 4.66 | 17.57 | -- | -12.94 | -- | -13.30 | -- | 41.69 | -- | -2,736.49 | -- | 33.80 | -- | -- | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| Pharma Foods International Co., Ltd. | 65.08bn | 4.76bn | 25.68bn | 670.00 | 5.35 | 2.69 | 4.78 | 0.3945 | 165.17 | 165.17 | 2,257.80 | 327.80 | 1.84 | 2.22 | 12.71 | 97,135,820.00 | 13.44 | 8.40 | 48.12 | 19.20 | 79.89 | 81.34 | 7.32 | 3.85 | 0.8449 | 91.33 | 0.6839 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
| StemRIM Inc | 2.35bn | 179.40m | 28.54bn | 44.00 | 135.55 | 2.91 | -- | 12.14 | -0.1097 | -0.1097 | 37.43 | 159.71 | 0.2453 | -- | -- | 53,409,090.00 | 1.87 | -6.71 | 1.89 | -6.83 | -- | -- | 7.63 | -45.80 | 78.90 | 652.72 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| SanBio Co Ltd | 0.00 | -2.64bn | 31.23bn | 29.00 | -- | 11.07 | -- | -- | -40.50 | -40.50 | 0.00 | 41.11 | 0.00 | -- | -- | 0.00 | -43.74 | -42.00 | -52.38 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1923 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
| Mizuho Medy Co Ltd | 11.34bn | 4.00bn | 32.58bn | 180.00 | 8.15 | 2.13 | 7.77 | 2.87 | 419.74 | 419.74 | 1,190.62 | 1,607.77 | 0.6484 | 1.87 | 2.99 | 62,999,830.00 | 22.86 | 31.46 | 26.23 | 39.78 | 73.41 | 74.85 | 35.25 | 33.64 | 6.41 | -- | 0.00 | 34.83 | -37.49 | 11.34 | -51.85 | 32.64 | -17.74 | 32.85 |
| Koa Shoji Holdings Co Ltd | 22.67bn | 2.87bn | 34.23bn | 297.00 | 11.93 | 1.51 | 9.56 | 1.51 | 72.45 | 72.45 | 572.11 | 573.53 | 0.7878 | 5.56 | 2.62 | 76,317,420.00 | 9.98 | 7.91 | 12.08 | 9.93 | 29.95 | 28.74 | 12.66 | 10.48 | 3.86 | 36.55 | 0.1142 | 19.64 | 8.35 | 8.27 | 13.90 | 29.60 | -21.26 | 15.52 |
| Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 36.29bn | 1.01k | 11.12 | 0.6981 | 5.34 | 0.8031 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
| Fuji Pharma Co Ltd | 43.05bn | 5.92bn | 37.58bn | 1.62k | 6.23 | 0.8376 | 4.08 | 0.8728 | 243.57 | 243.57 | 1,771.38 | 1,812.38 | 0.5071 | 1.34 | 3.21 | 26,558,910.00 | 6.97 | 4.10 | 10.56 | 5.58 | 39.78 | 42.41 | 13.75 | 7.55 | 0.5895 | -- | 0.3826 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
Data as of May 23 2024. Currency figures normalised to Pharma Foods International Co Ltd's reporting currency: Japanese Yen JPY
12.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 829.20k | 2.85% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 816.57k | 2.81% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 394.90k | 1.36% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 387.60k | 1.33% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 359.90k | 1.24% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 222.30k | 0.76% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 170.00k | 0.59% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 2024 | 164.50k | 0.57% |
| BlackRock Fund Advisorsas of 09 May 2024 | 82.50k | 0.28% |
| BlackRock Japan Co. Ltd.as of 09 May 2024 | 68.80k | 0.24% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
